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Neoadjuvant chemotherapy (NAC)Purpose: The purpose of this work was the evaluation of new advances of magnetic resonance imaging
(MRI) in diagnosis of recurrent breast cancer after conservative surgery, chemotherapy and radiotherapy.
Introduction: Breast conservation surgery followed by breast radiotherapy and chemotherapy produces
changes on both physical examination and on post-treatment breast imaging. Distinguishing these
normal treatment-related findings from breast cancer recurrence in the original lumpectomy site or
elsewhere in the breast (new primary tumors) is challenging.
Introduction: Our prospective study is done on fifty female patients who had undergone breast-
conserving therapy at least 6 months since the end of radiation therapy. All cases were suspected for
either recurrence or post-operative complications by clinical examination in conjunction with mammog-
raphy and/or US. Confirmation of different lesions was achieved by fine needle aspiration biopsy, core or
excisional biopsy. All patients were examined by dynamic contrast enhanced MRI (DCE-MRI). If one of
imaging modalities suspected recurrence, all of the imaging modalities were performed.
From our study we concluded that MRI is useful examination that can provide very valuable information
in patient with suspected recurrence. It is a technique that offers not only information on lesion cross sec-
tional morphology but also on functional lesion features such as tissue perfusion and enhancement
kinetics.
 2016 The Egyptian Society of Radiology and Nuclear Medicine. Production and hosting by Elsevier. This
is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/
4.0/).1. Introduction
A close follow up of patients after breast conserving therapy
(BCT) is necessary because tumor recurrence ranges between 1%
and 2% per year. It typically occurs 3–7 years after BCT. Early detec-
tion of local recurrence of breast cancer has been shown to signif-
icantly improve long-term survival [1].
Breast conservation surgery followed by breast radiotherapy
produces changes on both physical examination and post-
treatment breast imaging. Detection of local tumor recurrence, as
well as evaluation of the remainder of the breast tissue by conven-
tional methods can be difficult due to post treatment alteration,
especially within dense breasts; hence, repeated biopsy is often
required [2].
The breast conservative surgery including lumpectomy, partial
mastectomy, and segmentectomy is aiming at surgical excision ofthe breast cancer with a surrounding margin of histologically
normal breast parenchyma while conserving the patient’s breast
appearance and form. Breast conservative surgery is the most com-
mon surgical option for patients with early stages of breast cancer,
typically T1 or T2 [3].
Chemotherapy leads to necrosis and fibrosis, which appear as
persistent density on mammogram. Similarly, calcifications associ-
ated with a carcinoma can persist even when the viable tumor cells
are no longer present. Both persistent density and calcification can
be incorrectly identified as carcinoma on mammogram, resulting
in false positive results [4], Moreover mammographic evaluation
within the 1st 12 months after radiation is frequently impaired
by radiation induced changes.
Ultrasound (US) may be of limited ability in detection of neo-
plastic recurrence, as it is operator dependent, and the hypoe-
chogenicity with posterior acoustic shadowing at the site of
scarring tissue can limit the proper evaluation due to their similar-
ity to patterns seen with recurrent tumors. There is also dimin-
ished reliability of US for detection of small and non-invasive
cancers, even in the untreated breasts. Extensive scarring after
multiple operations or complicated healing can cause diagnosticol Nucl
2 O.I. Saleh et al. / The Egyptian Journal of Radiology and Nuclear Medicine xxx (2016) xxx–xxxproblems making the exclusion or the demonstration of neoplastic
recurrence too difficult [5].
DCE-MRI has been shown to aid significantly in detection and
characterization of primary and recurrent breast cancers. The sen-
sitivity of breast MR imaging for detection of residual and recur-
rent tumors in the post-operative breast is over 90%. Breast MR
imaging has been shown to be useful in differentiating scar tissue
from tumor recurrence regarding the non-enhancing areas which
have a high negative predictive value for malignancy (88–96%) [1].
It is also a valuable technique and more specific in differentia-
tion of post irradiation changes from recurrent carcinoma in
patients who had undergone breast irradiation [4].
DCE-MRI together with MR spectroscopy is known to enable the
most accurate assessment of tumor response in breast cancer after
neoadjuvant chemotherapy (NAC) in comparison with other con-
ventional techniques. It is able to monitor complete, partial and
poor response [6].
2. Patients and methods
Fifty female patients were subjected to this prospective study,
their ages ranged from 27 to 67 years with mean of 47 years, the
study was done at Alazhar University Hospitals in the period
between June 2014 and October 2015, the patients were referred
to the Radio-diagnosis Department from the general and oncology
surgery units. Also outpatients were included. All cases had under-
gone BCT with at least 6 months spare period since the end of irra-
diation therapy. All cases were suspected for either recurrence or
post-operative complications by the clinical examination in con-
junction with mammography and US. Confirmation of different
lesions was achieved by fine needle aspiration cytology, core or
excisional biopsy.
All patients were instructed to come whenever possible during
the 1st half of the cycle to avoid the associated prominent
enhancement of the breast parenchyma due to the physiological
hormonal effect that may obscure or mimic the malignancy.
All patients had undergone one of the different approaches of
BCT with or without post-operative irradiation and chemotherapy.
Forty-one patients were submitted to post-operative radiation
and chemotherapy; the remaining 9 patients were submitted to
surgery alone.
An irradiation therapy and NAC were mainly given after surgery
in cases with +ve axillary lymph nodes, large 1ry tumor (>2 cm),
1ry cancer of high grade (III) or if cancer cells were negative for
hormone receptors.
Inclusion criteria at MRI examination consisted of history of BCT
with suspicion of neoplastic recurrence either clinically or in mam-
mography and ultrasound. Exclusion criteria were the recent irra-
diation therapy (up to 6 months after termination of therapy) and
usual contraindications for performing MRI such as claustrophobia,
marked obesity, metal devices in the body, and pacemaker.
All patients were examined by MRI ± Mammograms and Ultra-
sound. If one of the imaging modalities suspected neoplastic recur-
rence, in such cases all of the imaging modalities were performed.
Specific breast history was taken regarding the patient breast
risk factors, family history, breast lumps, scars, or other areas of
complaint. The patient details are regarding the location, date,
and the results of previous breast biopsy. The patient also docu-
mented any use of exogenous hormonal therapy and the phase of
the menstrual cycle or menopause.
2.1. Technique of mammography
The mammogram was mainly performed to grossly confirm or
exclude the presence of a lesion and detect micro-calcifications.
The machine used was Stephanix 800S.Please cite this article in press as: Saleh OI et al. The role of magnetic resonanc
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and medio-lateral views and specific views such as magnified
and localization views for more proper evaluation of a suspicious
lesion were also done.2.2. Technique of ultrasound examination
The ultrasound was performed for specification and evaluation
of mammographically detected opacities and for exclusion of post
operative collections, residual or recurrent lesions. All ultrasound
examinations were performed on GE logiq S6 (using a high fre-
quency linear 12 L transducer with frequency range 4.5–13 MHz)
and Toshiba Xario SSA-660A (using a high frequency linear probe,
PLT 805 AT transducer with frequency range 6.2–12 MHz).2.3. Technique of magnetic resonance imaging
Before MRI scanning, the patient fulfilled an MRI safety form to
exclude contraindications of entering the strong magnetic field,
such as ferromagnetic vascular clips, metallic ocular fragments,
pacemakers, and implanted electromechanical devices. A qualified
person reviewed the standardized MRI safety forms before
scanning.
The qualified nurse placed MRI-compatible markers on the
patient’s breast to indicate lumps location or areas of concern
and annotated them on the history form; All MRI studies were per-
formed on a superconducting magnet system (1.5 T. Philips
Achieva, class II a, USA). All patients were placed in prone position
using a dedicated double phased array breast coil. The majority of
patients were comfortable for the duration of the entire scan with
both arms at their sides. The patients were instructed to ‘‘hold still”
during the scan time in order to obtain the best imaging quality. IV
catheter, was placed before scanning and continuously flushed by
normal saline solution.
The imaging protocol consisted of bilateral simultaneous axial
and coronal images of both breast, as well as sagittal images of
the diseased side.
An axial T1-weighted localizer sequence through both breasts
was initially taken, and precontrast T1W frames with and without
fat saturation were acquired in the axial plane (TSE; parallel imag-
ing; flip angle = 90; TR = 9.9 ms; TE = 4.2 ms; NEX, 1; 2–4 mm slice
thickness with no gap; matrix 512  192, FVO = 35) and also T2WI
(TSE; parallel imaging with TE 80–120 ms and TR at least 3000 ms.
2–4 mm slice thickness with no gap; matrix 512  192, FVO = 35).
For post contrast and dynamic series, intravenous injection of
0.1 mmol per/kg of gadopentetate dimeglumine (Gd-DTPA, Mag-
nevist) was done at flow rate 2 ml/s, followed by 20 ml flush (nor-
mal saline) at the start of the acquisition. Imaging time with this
frame was approximately 80 s. Axial T1 WIs with fat suppression
and subtracted images acquisition were done after the DCE-
series. For kinetic analysis and acquisition of time-signal intensity
curve, Axial fast 2D GRE acquisition was planned. Five 2D image
sets with fat suppression were performed within the first 7 min
following intravenous administration of contrast agent. A small
region of interest (ROI < 3 pixels) was placed selectively over the
most intensely enhancing area of the lesion. Signal intensity/Time
curves were constructed. Diffusion-weighted imaging (DWI) was
performed before the DCE-MRI acquisition in an axial plane using
a 2D spin echo-echo planar imaging (SE-EPI) sequence with a par-
allel acquisition technique using the signal intensity and two dif-
ferent B-values. To assess ADC value the region of interest (ROI)
was manually drawn avoiding the necrotic or cystic components
by referring to DCE-MRI and T2-weighted images; The ADC value
was calculated as the mean of the voxels within the ROI of the
tumor. For 1H spectroscopy, used for assessment of choline peak,e imaging in early detection of recurrent breast cancer. Egypt J Radiol Nucl
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than 1  1  1 cm.2.4. Histopathological correlation
US guided core biopsy was used for confirmation of different
lesions suspected by the performed imaging modalities. Informed
consent was obtained after patient discussion about the risks and
benefits of the procedure and alternatives to the procedure. The
patient lied supine on an examination table with the ipsilateral
arm resting above the head. In cases of large breast, an oblique
position was used. The lesion was localized with US guidance.
The skin was sterilized by povidone iodine. The transducer was
also cleaned with an antiseptic solution. A high-frequency elec-
tronically focused linear-array transducer was used. An automated
18-gauge, long-throw core biopsy needle was used.
The qualitative assessment of morphologic features of the sus-
pected lesion was recorded regarding the site, size, margins, detec-
tion of multifocality, unifocality, skin involvement or lymph node
involvement and type of enhancement as well as restricted or free
diffusion on DWI. The evaluation also included search for acute
post-operative changes (changes occurring during 1st several
weeks up to 6 months post-operative) including skin thickening,
hematoma, seroma, edema, granulation tissue formation and tis-
sue disruption. Chronic post-operative changes (occurring follow-
ing 6 months post operative) including scar tissue formation,
nipple retraction, development of dystrophic calcifications, fat
necrosis and architectural distortion.
Data collected were reviewed, and coding and statistical analy-
sis of collected data were done by using SPSS program (statistical
package of social science; SPSS Inc., Chicago, IL, USA) version 18
for Microsoft Windows. Frequency of occurrence was calculatedTable 1
Age distribution of the studied group with the ratios of the recurrent cases among each g
Age of the patient Pathologically proven recurrence
Negative Positive
N % N
27–47 (premenopausal) 19 55.88 11
47–67 (postmenopausal) 15 44.12 5
Total 34 100.00 16
Table 2
Family history of breast cancer among the studied group with the ratios of the recurrent
Family history of breast cancer Pathologically proven recurrence
Negative Positive
N % N
Present 13 38.24 9
Absent 21 61.76 7
Total 34 100.00 16
Table 3
Types of operation done among the studied group with the ratios of the recurrent cases a
Types of operation done Pathologically proven recurrence
Negative Positi
N % N
Lumpectomy 4 11.76 4
Lumpectomy with axillary dissection 23 67.65 9
Quadractomy with axillary dissection 7 20.59 3
Total 34 100.00 16
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Med (2016), http://dx.doi.org/10.1016/j.ejrnm.2016.09.018to describe qualitative data and chi-square-test (x)-was used to
find the difference between two qualitative variables. The level of
significance was taken at p-value of <0.05 with confidence level
95%. The results are represented in tables.3. Results
The patients were divided into two groups according to their
menstrual status. Thirty were premenopausal (age 27–47 years)
and twenty were postmenopausal (age 47–67 years).
Eleven cases with pathologically proven recurrence was noted
among the premenopausal group, while the postmenopausal group
showed only five recurrent cases (Table 1).
First and second degree positive family history was present in
twenty-two cases from which there were nine cases with patho-
logically proven recurrence while among the remaining twenty-
eight cases with negative family history there were seven cases
with pathologically proven recurrence (Table 2).
Number and ratios of the postoperative recurrent cases among
each group are illustrated in Table 3.
Forty-one patients were submitted to postoperative radiation
therapy and chemotherapy while the remaining nine patients were
not, and number and ratios of the recurrent cases among each
group are illustrated in Table 4.
Mammographic findings suspected recurrence in twenty-four
cases, of them fourteen cases were confirmed by pathological
examination and proved to be true recurrence, while the remaining
ten false positive cases were likely caused by irregular scarring tis-
sue, dystrophic calcifications and seromas with no evidence of
malignancy. Two pathologically proven recurrent cases were
missed by mammography. These two cases were ductal carcinoma
in situ and invasive ductal carcinoma located adjacent to theroup.
Chi-square
Total
% N % X2 P-value
68.75 30 60.00 0.310 0.577
31.25 20 40.00
100.00 50 100.00
cases among each group.
Chi-square
Total
% N % X2 P-value
56.25 22 44.00 0.577 0.372
43.75 28 56.00
100.00 50 100.00
mong each group.
Chi-square
ve Total
% N % X2 P-value
25.00 8 16.00 1.430 0.489
56.25 32 64.00
18.75 10 20.00
100.00 50 100.00
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Table 4
Submission to postoperative radiation therapy and chemotherapy among the studied group with the ratios of the recurrent cases among each group.
Postoperative radiation therapy and chemotherapy Pathologically proven recurrence Chi-square
Negative Positive Total
N % N % N % X2 P-value
Given 29 85.29 12 75.00 41 82.00 0.239 0.624
Not given 5 14.71 4 25.00 9 18.00
Total 34 100.00 16 100.00 50 100.00
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sitivity, specificity, accuracy as well as positive and negative pre-
dictive value are represented in Table 5.
The ultrasound examinations agreed with mammography in
twenty cases only. The remaining four cases suspected by mam-
mography were proved to be three cases with seroma and one case
with dystrophic calcifications within the postoperative scar
(appeared as suspicious calcifications on mammogram). The US
findings suspected recurrence in five false positive cases and
missed the diagnosis (revealed no suspicious findings) in one false
negative case. The maximum diameters of tumors noted by US ran-
ged from 13 mm to 26.5 mm and the mean maximum diameters of
the tumors were about 22.5 mm. The ultrasound sensitivity, speci-
ficity, accuracy as well as positive and negative predictive value are
represented in Table 6.
The magnetic resonance mammography (MRM) revealed suspi-
cious morphological and kinematic findings for recurrence in eigh-
teen cases, of them sixteen recurrent cases were confirmed
pathologically. The remaining two false positive cases were patho-
logically proved to be granulomatous reaction with no evidence of
malignancy, both cases showed regional non mass enhancement at
the operative bed with type II time-signal intensity curves on
kinetic analysis. The maximum diameters of tumors noted by
MRI ranged from 16.5 mm to 32 mm and the mean maximum
diameters of the tumors were about 27.5 mm. The MRM sensitiv-Table 5
Correlation between mammographic and pathological findings among the studied group. P
Mammography Pathologically proven recurrence
Negative Positive
N % N %
Negative 24 70.59 2 12.5
Positive 10 29.41 14 87.5
Total 34 100.00 16 100
ROC curve Sensitivity Specificity
87.50 70.59
* P-value 6 0.05.
Table 6
Correlation between ultrasound and pathological findings among the studied group. PPV
U/S Pathologically proven recurrence
Negative Positive
N % N %
Negative 29 85.29 1 6.25
Positive 5 14.71 15 93.75
Total 34 100.00 16 100.00
ROC curve Sensitivity Specificity
93.75 85.29
* P-value 6 0.05.
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value are represented in Table 7.
In correlating the site of the suspicious findings in MRM to the
operative tumor bed, twelve cases were noted at the operative bed
(including the two false positive cases). Four cases were seen away
from the operative bed in the same breast and two cases at the
contralateral breast (Table 8).
Of the eighteen cases suspected by MRM, eleven cases were
noted as enhancing mass lesion with suspicious morphology, while
the remaining seven cases presented as focal, regional or linear
areas of non-mass enhancement (Table 9).
On kinetic analysis eleven cases showed type III time-signal
intensity curves with rapid wash in and delayed wash out. The
remaining seven cases showed type II time-signal intensity curves
with rapid wash in and delayed plateau (Table 10).
Quantitative diffusion weighted imaging of the 18 cases sus-
pected byDCE-MRI (including the two false positive cases) revealed
low ADC values in the range of 0.8–1.45  103 mm2/s, with amean
ADC of 1.2  103 mm2/s and cut off value of 1.3  103 mm2/s. 17
cases were below and only one case above this limit
(1.45  103 mm2/s). 1H MRS analysis of the eighteen cases sus-
pected by DCE-MRI, revealed high choline peak in fifteen cases. For-
teen cases of them were positively correlated with the
histopathological data. Absent choline peak were noted in three
cases includingoneof the falsepositive cases suspectedbyDCE-MRI.PV positive predictive value, NPV negative predictive value, sensitivity and specificity.
Chi-square
Total
N % X2 P-value
0 26 52.00 12.473 0.0004*
0 24 48.00
.00 50 100.00
PPV NPV Accuracy
58.33 92.31 76.00
positive predictive value, NPV negative predictive value, sensitivity and specificity.
Chi-square
Total
N % X2 P-value
30 60.00 25.126 <0.001*
20 40.00
50 100.00
PPV NPV Accuracy
75.00 96.67 88.00
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Table 8
The location of the MRM suspicious findings in relation to the operative tumor bed.
Location MRI (n = 18)
N %
Tumor operative bed 12 66.67
Same breast away from the operative bed 4 22.22
Contralateral breast 2 11.11
Total 18 100.00
Table 9
Different types of enhancement of the MRM suspicious lesions.
Type of lesion MRI (n = 18)
N %
Enhancing mass lesions 11 61.11
Non-mass enhancement 7 38.89
Total 18 100.00
Table 10
Different types of time-signal intensity curves obtained after kinetic analysis of the
MRM suspicious lesions.
Type of curve MRI (n = 18)
N %
Type III curve 11 61.11
Type II curve 7 38.89
Total 18 100.00
Table 12
Types of skin thickening among the studied cases.
Skin thickening
N %
Focal 15 30.00
Diffuse 35 70.00
Total 50 100.00
Table 13
Histopathological types of the recurrent masses.
Histopathological types
N %
Invasive ductal carcinoma 11 68.75
Invasive lobular carcinoma 4 25.00
Ductal carcinoma in situ 1 6.25
Total 16 100.00
Table 7
Correlation between MRM and pathological findings among the studied group. PPV ositive predictive value, NPV negative predictive value, sensitivity and specificity.
MRM Pathologically proven recurrence Chi-square
Negative Positive Total
N % N % N % X2 P-value
Negative 32 94.12 0 0.00 32 64.00 37.845 <0.001*
Positive 2 5.88 16 100.00 18 36.00
Total 34 100.00 16 100.00 50 100.00
ROC curve Sensitivity Specificity PPV NPV Accuracy
100.00 94.12 88.89 100.00 96.00
* P-value 6 0.05.
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1H MRS analysis of the suspected lesions, the overall MRM speci-
ficity increased to 97%.
Post-operative fibrosis in the operation bed was noted by the
MRM, showing no enhancement in twenty-one cases. In twenty-
seven cases the scarring tissue presented with mild enhancement
with type I curve on kinetic analysis. Only two cases showed regio-
nal non mass enhancement that were non separable from the scar-
ring tissue at the operative bed and revealed type II time-signalTable 11
The presentation of post-operative scarring tissue on dynamic MRI examination.
Post-operative scarring
N %
Non enhancing scarring tissue 21 42.00
Mildly enhancing scarring tissue with type
I time-signal intensity curve
27 54.00
Mildly enhancing with type II time-signal
intensity curves
2 4.00
Total 50 100.00
Please cite this article in press as: Saleh OI et al. The role of magnetic resonanc
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and revealed granulomatous reaction (Table 11).
Focal skin thickening was found among fifteen cases while dif-
fuse thickening was found in thirty-five cases represented in
Table 12.
The histopathological types of the pathologically proven recur-
rent masses are represented in Table 13.4. Discussion
The recurrence of the tumor in a conservatively treated breast
usually occurs at the lumpectomy bed, adjacent to the operative
margin, However it may recur elsewhere in the breast. The major-
ity of true local recurrences arise close to the original primary site,
while the new primaries are most often seen outside the original
quadrant [7]. On mammography, commonly encountered benign
post treatment changes include skin thickening and edema, focal
fluid collections representing hematoma or seroma, developing
coarse or dystrophic calcifications in or near the surgical bed,
and scarring. These changes usually result in increased density
and surgical bed deformity which are in conjunction with dys-
trophic benign calcifications and dense breasts of young patients,
compromise the ability of mammography to show the tumor in
the treated breast. All of the previously described issues are the
reasons for relatively decreased mammographic sensitivity, and
specificity in our study which is 87.5% and 70.59%, respectively [2].
In our study, microcalcifications are noted only in three recur-
rent cases (Fig. 1) while dystrophic benign calcifications are seen
in one case with no corresponding suspicious abnormalities on
the US or MRI. The low prevalence of microcalcifications in thise imaging in early detection of recurrent breast cancer. Egypt J Radiol Nucl
Fig. 1. 43 years old patient presented with history of right breast ductal carcinoma and was submitted to quadractomy and axillary dissection with postoperative radiation
and chemotherapy. (A) Mammogram shows heterogeneous ill-defined increased density (black arrows) at the retro-areolar region with irregular outline and multiple foci of
microcalcifications (white arrow), thickened skin and retracted nipple (arrow head) are noted. (B) Ultrasonography shows heterogeneous ill-defined soft tissue mass lesion at
retro-areolar region (black arrows) showing mainly hypoechoic texture and irregular outline. Thickened skin (arrow heads) and parenchymal edema (white arrow) were seen.
(C, D, E) Axial T2 WI MRI revealed large infiltrative ill-defined soft tissue mass lesion (black arrows) at the retro-areolar region showing heterogeneous intermediate signal
alteration and irregular outlines. Diffuse edema of the breast parenchyma and pectoralis major muscle (white arrows) are seen. Thickened skin and retracted nipple (arrow
heads) are also noted. Right axillary rounded lymph nodes and hepatic focal lesions are seen (open arrows). (F, G) Axial T1WI MRI with fat suppression before and after IV
contrast administration revealed moderate homogenous post contrast mass enhancement (white arrows). (H) Kinetic analysis revealed type III time-signal intensity curve
with rapid wash in and delayed wash out (indicative of malignancy). (I) Corresponding diffusion WI revealed low ADC value (1.1  103 mm/s) seen as hypointense signal
(denoting diffusion restriction of malignancy) at the site of the lesion while hyperintensity (denoting no restriction and benignity) is seen at the site of edema. Hepatic focal
lesions are also seen on DWI (open arrows). (J) MRS analysis revealed high choline peak at 3.2 ppm (white arrow) indicative of malignancy.
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Fig. 2. 60 years old patient presented with history of left breast lobular carcinoma that was treated by radical mastectomy, the patient developed a contralateral right breast
carcinoma later on and the patient was treated by lumpectomy and axillary dissection with postoperative radiation and chemotherapy. (A) Right breast mammogram shows
prominent regional increased breast density and heterogeneous ill-defined speculated opacity (black arrows) seen at the retro-areolar region showing irregular outlines and
foci of microcalcifications (white arrow). Marked diffuse skin thickening and retracted nipple (arrow heads) are also seen. (B) Ultrasonography shows retro-areolar soft tissue
mass lesion with heterogeneous hypoechoic texture and ill-defined irregular outlines (black arrows), marked glandular tissue edema (white arrow) and thickened skin (arrow
heads) are seen. (C, D) Axial T1 & T2WMRI shows marked edema of the breast parenchyma (black arrows), thickened skin (white arrows) and retracted nipple. (E and F) Axial
T1WI with fat suppression before and after IV contrast administration show irregular ill-defined soft tissue mass lesion at retro-areolar region with marked post contrast
enhancement (black arrows). Linear areas of high signal on pre-contrast images (white arrows) are likely related to lactiferous ducts filled with proteinaceous material or
blood. (G) Kinetic analysis revealed type III time-signal intensity curve with rapid wash in followed by wash out (indicative of malignancy). (H) Corresponding MRS revealed
high choline peak (white arrow). Diffusion WI (not shown) revealed low ADC value (0.8  103 mm/s) indicative also of malignancy.
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noma in situ among pathologically proven cases.
Assessment by US is known and valuable tool when recurrent
masses are suspected. Hasan et al. [9] in their study carried on
fifty-seven breast cancer patients, stated that the accuracy of US
for residual lesion around the previous scar is even higher than
that of MRI. However, its sensitivity considerably lower.
On the other hand problems encountered with US include
hypoechoic areas, posterior acoustic shadowing within the scar tis-
sue, and fat necrosis which had a similar appearance to that of
breast lumps as well as other distinct lesions from the primary can-
cer and multifocal lesions [9].
In our study, US was a reliable test if the mammogram result is
negative. US recorded sensitivity and specificity of 93.75% and
85.29% respectively which were higher than those of mammogra-
phy. Mammographic false positive results caused by seroma,
abscess and dystrophic calcifications were easily identified by
ultrasonography.
All previously mentioned reasons made the DCE-MRI a useful
additional examination in patient with suspected recurrence. It
has known and well established advantages over conventional
breast imaging for the detection of malignancy. These advantages
are as follows absence of ionizing radiation, all imaging planes
are possible, capability of imaging the entire breast volume and
chest wall, images are reproducible and non-operator dependent,
3-D mapping of the lesion with techniques such as maximum
intensity projection slab 3-D reconstruction, higher sensitivity to
invasive carcinoma and accurate estimation of its size, detection
of occult, multi-focal or residual malignancies and its ability to
image regional lymph nodes.
Dynamic contrast enhanced DCE-MR in our study detected the
recurrence and differentiated it from non-enhanced scar tissue
with high sensitivity and specificity. The true recurrent cases
detected were sixteen out of a total eighteen suspected cases.
Recurrence away from operative bed in multifocal and multicentric
lesions is detected by MRI in six cases (4 cases in the same breast
away from operative bed and 2 cases in the contra lateral breast)
(Fig. 2). This is one of the advantages of the MRI over the US which
usually misses these multifocal and multi-centric lesions [8].
Two false positive cases are found presented as focal areas of
non-mass enhancement with type II time-signal intensity curve
on kinetic analysis, after US guided true cut biopsy of the suspi-
cious lesions, both were reported pathologically as a granuloma
with no evidence of malignant cells infiltration. Hyunkyung et al.
[11] stated seven false positive cases among a total number of six-
teen cases showing suspicious MRM features and claimed it due to
short post radiation period (12 month). The scarring tissue
enhanced after the operation by 6 month without radiation and
up to 18 month after the radiotherapy.
One of these two false positive cases showed relatively high
ADC value (1.4  103 mm2/s) on quantitative DWI. Also, the
lesional 1H MR spectroscopic analysis revealed no choline peak,
meaning that specificity of the MRM is increased when additional
DWI and 1H MRS are planned. Among the studies that examined
the role of diffusion weighted imaging on improving the MRM sen-
sitivity and specificity, Jiang et al. [17] also concluded that combi-
nation of quantitative kinetic parameters and ADC showed higher
diagnostic performance for predicting malignancy than each
parameter alone for the evaluation of patients with breast cancer.
Kaplan et al. [4] stated that when applying an ADC cut off value of
1.33 the specificity and PPV of DCE-breast MRI increased from
59.5% and 75–78.5% and 83.3%, respectively. The diagnostic perfor-
mance of Magnetic resonance spectroscopy (MRS) in recurrent
breast masses following BCT was also evaluated by Khattab et al.
[13] and achieved a sensitivity of 94.7%, specificity of 85.7% and
overall accuracy of 92.3%.Please cite this article in press as: Saleh OI et al. The role of magnetic resonanc
Med (2016), http://dx.doi.org/10.1016/j.ejrnm.2016.09.018Significant difference between US and MRI in the size and
extension of the recurrent disease was noted in this study. The
mean maximum diameter of tumors by US was about 22.5 mm
while on the corresponding MRI the mean maximum diameter of
tumors was about 27.5 mm. There is a statistically significant dif-
ference of 5 mm.
The overall sensitivity of the DCE-MRM in our study was 100%.
The specificity and accuracy were 94.12% and 96%, respectively.
With addition of quantitative diffusion weighted imaging and 1H
MRS analysis of the suspected lesions, the overall MRM specificity
increased to 97%.
Our results support the increased prevalence of local recurrence
among younger age group. As 11 recurrent cases were noted
among a total number of thirty cases aged 27–47 years while
among the group aged 47–67 years (20 cases) only 5 recurrent
cases were noted which was also proved by another study carried
on 209 premenopausal women [14], stated that the age remains
the first prognostic factor for regional breast cancer recurrence in
women treated with breast conserving surgery with the relative
risk of local recurrence increased by 7% for every decreasing year
of age.
The first and second degree positive family histories are present
in twenty-two cases from which there were nine cases with patho-
logically proven recurrence. Among the remaining twenty-eight
cases with negative family history there were seven cases with
pathologically proven recurrence. The impact of positive family
history on local recurrence after breast-conserving therapy was
performed within a better framework of a large, multicenter
matched case-control study [16] establishing that the local recur-
rence risk after BCT for patients with a positive family history
was similar to or less than that of patients without a family history
of breast cancer.
Post-operative radiation and chemotherapy were given for forty
one cases with recurrence noted in 12 cases of them (accounting
for a percentage of 29.2%) while post-operative radiation and
chemotherapy were not given for the remaining nine cases among
which four recurrent cases were noted (accounting for a percent-
age of 44.4%). These results are suggestive of increased recurrence
rates in case of avoidance of post-operative irradiation and
chemotherapy. Similar results were obtained from similar previous
study (18) establishing that the avoidance of radiotherapy and
tamoxifen after breast-conserving surgery increases the rate of
local recurrences substantially by about three times.5. Conclusion
From our study we concluded that MRI is useful examination
that can provide very valuable information in patient with sus-
pected recurrence. Compared to mammography and breast ultra-
sonography. The DCE-MRI is a technique that offers not only
information on lesion cross sectional morphology but also on func-
tional lesion features such as tissue perfusion and enhancement
kinetics. It was able to detect residual or recurrent disease of pre-
viously treated breast cancer, differentiating them from post treat-
ment changes with the greatest sensitivity and specificity. Addition
of quantitative diffusion weighted imaging and 1H MRS analysis of
the suspected lesions to the routine MRM protocol is recom-
mended as both are suggested to increase the overall MR speci-
ficity, preventing unnecessary invasive procedures or surgical
interventions.Conflict of interest
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